CVS Health Q3 Adjusted EPS $2.21 Beats $2.13 Estimate, Sales $89.76B Beat $88.25B Estimate
Portfolio Pulse from Benzinga Newsdesk
CVS Health reported Q3 earnings of $2.21 per share, beating the analyst consensus estimate of $2.13 by 3.76%. This is a 1.84% increase from the same period last year. The company also reported quarterly sales of $89.76 billion, beating the analyst consensus estimate of $88.25 billion by 1.72%. This is a 10.60% increase from the same period last year.
November 01, 2023 | 10:34 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
CVS Health's Q3 earnings and sales beat analyst estimates, indicating a strong financial performance.
CVS Health's Q3 earnings and sales exceeded analyst estimates, which is a positive signal for the company's financial health. This could lead to increased investor confidence and potentially a rise in the stock price in the short term.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100